10x Genomics Gross Profit 2018-2024 | TXG
10x Genomics gross profit from 2018 to 2024. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| 10x Genomics Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2023 | $409 |
| 2022 | $396 |
| 2021 | $416 |
| 2020 | $240 |
| 2019 | $185 |
| 2018 | $118 |
| 2017 | $61 |
| 10x Genomics Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2024-09-30 | $106 |
| 2024-06-30 | $104 |
| 2024-03-31 | $93 |
| 2023-12-31 | $116 |
| 2023-09-30 | $96 |
| 2023-06-30 | $100 |
| 2023-03-31 | $98 |
| 2022-12-31 | $119 |
| 2022-09-30 | $101 |
| 2022-06-30 | $87 |
| 2022-03-31 | $89 |
| 2021-12-31 | $116 |
| 2021-09-30 | $101 |
| 2021-06-30 | $111 |
| 2021-03-31 | $89 |
| 2020-12-31 | $93 |
| 2020-09-30 | $57 |
| 2020-06-30 | $33 |
| 2020-03-31 | $57 |
| 2019-12-31 | $59 |
| 2019-09-30 | $46 |
| 2019-06-30 | $41 |
| 2019-03-31 | $40 |
| 2018-12-31 | |
| 2017-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.773B | $0.619B |
| 10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.872B | 57.28 |
| Tempus AI (TEM) | United States | $10.232B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.842B | 224.83 |
| Inspire Medical Systems (INSP) | United States | $5.430B | 169.35 |
| IRhythm Technologies (IRTC) | United States | $3.397B | 0.00 |
| Privia Health (PRVA) | United States | $2.723B | 226.90 |
| Enovis (ENOV) | United States | $2.544B | 16.95 |
| Azenta (AZTA) | United States | $2.469B | 114.98 |
| Clover Health Investments (CLOV) | United States | $2.225B | 0.00 |
| Schrodinger (SDGR) | United States | $1.886B | 0.00 |
| Omnicell (OMCL) | United States | $1.826B | 39.83 |
| Phreesia (PHR) | United States | $1.680B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.937B | 0.00 |
| Talkspace (TALK) | United States | $0.608B | 0.00 |
| Standard BioTools (LAB) | United States | $0.529B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
| TruBridge (TBRG) | United States | $0.380B | 110.57 |
| Nyxoah SA (NYXH) | Belgium | $0.369B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| American Well (AMWL) | United States | $0.176B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.104B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.073B | 0.00 |
| CareCloud (CCLD) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |